MedPath
NMPA Approval

Ibuprofen Suspension

国药准字H20244207

June 28, 2024

Drug Information

布洛芬混悬液

口服混悬剂

100毫升:2克

化学药品

June 28, 2024

Company Information

Applicant Company

广州市萝岗区开源大道196号自编1-2栋

Manufacturing Company

吉林省四平市开发区路3288号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬液 - NMPA 批准文号 | MedPath